VIP Research
Udupa 2025 — Aviptadil Therapy in ARDS Systematic Review and Meta-Analysis
Journal of Intensive Care Medicine·January 1, 2025
A. A. Udupa, et al.
Summary
Systematic review evaluating whether aviptadil improves survival and oxygenation outcomes in ARDS. Useful for presenting VIP/aviptadil as investigational rather than proven.
Study Details
Study Design
Systematic review and meta-analysis
Indication
Acute respiratory distress syndrome
Intervention
Aviptadil / vasoactive intestinal peptide
Species
Human
Risk of Bias Assessment
Meta-analysis; limited underlying trial base
Tags
SourceSystematic ReviewVipAviptadilArdsRespiratory FailureInvestigational
External Links
Metrics
Citations
1Evidence QualityN/A
Last VerifiedMay 9, 2026
Related PeptideVIP2 papers